INOGEN INC (INGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for INGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| INGN | Director, Chairperson of the Compliance Committee | 69 | [] | ["Compliance Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FRSH | Chief Development Officer | 50 | [] | [] | 2015 |
Biography sourced from the proxy statement filing.
Kevin King has served on our Board and is currently the Chairperson of the Compliance Committee and a member of our Audit Committee. Mr. King also served as Chairperson of the Compensation Committee from March 2022 to March 2024. He has over three decades of experience in the healthcare and IT industries in leadership roles. Mr. King previously served as Chief Executive Officer, President and Director of iRhythm Technologies, Inc. (Nasdaq: IRTC), a digital healthcare company, from July 2012 to April 2021. Prior to iRhythm, Mr. King was President, Chief Executive Officer and a Director of Affymetrix, Inc.(Nasdaq: AFFX), an innovator in the field of genetic analysis from 2007 to 2011. He served as President and Chief Executive Officer of Thomson Healthcare, an information services business which focused on a range of healthcare-related businesses. Mr. King was a senior executive at GE Healthcare, where he led several business units from 1997 to 2005. Mr. King held leadership roles at Hewlett Packard's Medical Products Group. Mr. King has served on the Board of Directors of Turing Medical, a private company, since June 2023. Mr. King holds a B.A. in Economics and Biology from the University of Massachusetts and an M.B.A. from New Hampshire College. Qualifications: The Board believes that Mr. King is qualified to serve as a director based on his extensive leadership experience in the healthcare and information technology industries and his significant public company governance experience. Mr. King has served as Chief Executive Officer, President, and Director of multiple publicly traded healthcare technology companies, including iRhythm Technologies, and brings valuable perspective on strategic growth, technology commercialization, and scaling organizations. He offers experience in capital markets, cybersecurity and data protection, global operations, and enterprise risk management, as well as direct experience with home-based healthcare technologies. Mr. King has also led talent development and executive compensation programs and has significant public company board experience, supporting effective governance and oversight.